Prevalence of dyslipidemia in urban and rural India: The ICMR-INDIAB study

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Joshi, Shashank R ^a   Anjana, Ranjit Mohan ^b   Deepa, Mohan ^b   Pradeepa, Rajendra ^b   Bhansali, Anil ^c   Dhandania, Vinay K ^d   Joshi, Prashant P ^e   Unnikrishnan, Ranjit ^b   Nirmal, Elangovan ^b   Subashini, Radhakrishnan ^b   Madhu, Sri Venkata ^f   Rao, Paturi Vishnupriya ^g   Das, Ashok Kumar ^h   Kaur, Tanvir ⁱ   Shukla, Deepak Kumar ⁱ   Mohan, Viswanathan ^b  

^a LILAVATI HOSPITAL AND RESEARCH CENTRE   (India)

^b MADRAS DIABETES RESEARCH FOUNDATION   (India)

^c POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^d Diabetes Care Center   (India)

^e GOVERNMENT MEDICAL COLLEGE   (India)

^f UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^g NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^h JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

ⁱ INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LIPID;

ADULT; AGE DISTRIBUTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; CAPILLARY BLOOD; CHOLESTEROL BLOOD LEVEL; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DYSGLYCEMIA; DYSLIPIDEMIA; FEMALE; GEOGRAPHIC DISTRIBUTION; GLUCOSE BLOOD LEVEL; HEALTH DISPARITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INDIA; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; RESIDENTIAL AREA; RISK FACTOR; URBAN RURAL DIFFERENCE; AGED; BLOOD; DYSLIPIDEMIAS; EPIDEMIOLOGY; MIDDLE AGED; RURAL POPULATION; SEX RATIO; STATISTICS AND NUMERICAL DATA; URBAN POPULATION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; DYSLIPIDEMIAS; FEMALE; HUMANS; INDIA; LIPIDS; MALE; MIDDLE AGED; PREVALENCE; RURAL POPULATION; SEX DISTRIBUTION; URBAN POPULATION; YOUNG ADULT;

EID: 84901228025     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096808     Document Type: Article

References (31)

1. Mathers C, Fat DM, Boerma JT (2008) for World Health Organization. The Global Burden of Disease: 2004 Update. Geneva: World Health Organization.
2. Fuster V, Kelly BB, editors (2010) Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. Washginton, DC: National Academies Press.
3. Sample Registration System (2007) Million Death Study: Preliminary Report on Causes of Death in India 2001-2003. New Delhi: Registrar General of India.
4. Enas EA, Yusuf S, Mehta J (1992) Prevalence of coronary artery disease in Asian Indians. Am J Cardiol 70: 945-949.
5. Omran AR (1971) The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q 49: 509-538.
6. Groundy SM, Small LDL (1997) Atherogenic dyslipidemia and the metabolic syndrome. Circulation 95: 1-4.
7. Haffnar M (1999) Diabetes, hyperlipidemia and coronary artery disease. Am J Cardiol 83(Suppl): 17F-21F.
8. Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, et al (2011) ICMR-INDIAB Collaborative Study Group. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia 54: 3022-3027.
9. Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, et al (2011) The Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study: methodological details. J Diabetes Sci Technol 5: 906-914.
10. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) (2001) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
11. World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF Consultation, Geneva, World Health Organization, p 39.
12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC-7). JAMA 289: 2560-2571.
13. World Health Organization (2000) The Asia Pacific perspective. Redefining obesity and its treatment. World Health Organization. International Association for the study of Obesity and International Obesity Task Force. Melbourne International Diabetes Institute.
14. Rose GA, Blackburn H, Gilium RF, Prineas RJ (1982) Cardiovascular survey methods. 2nd ED. Minnesota code for resting Electrocardiograms. Minnesota Code p 124-143.
15. Bull FC, Maslin TS, Armstrong T (2009) Global physical activity questionnaire (GPAQ): nine country reliability and validity study. J Phys Act Health 6: 790-804.
16. Misra R, Patel T, Kotha P, Raji A, Ganda O, et al (2010) Prevalence of diabetes, metabolic syndrome, and cardiovascular risk factors in US Asian Indians: results from a national study. J Diabetes Complications 24: 145-153.
17. Khader YS, Batieha A, El-Khateeb M, Al Omari M, Ajlouni K (2010) Prevalence of dyslipidemia and its associated factors among Jordanian adults. J Clin Lipidol 4: 53-58.
18. Erem C, Hacihasanoglu A, Deger O, Kocak M, Topbas M (2008) Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon Lipid Study. Endocrine 34: 36-51.
19. Zahid N, Claussen B, Hussain A (2008) High prevalence of obesity, dyslipidemia and metabolic syndrome in a rural area in Pakistan. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2: 13-19. (Pubitemid 351194191)
20. Reddy KS, Prabhakaran D, Chaturvedi V, Jeemon P, Thankappan KR, et al (2006) Methods for establishing a surveillance system for cardiovascular diseases in Indian industrial populations. Bulletin of the World Health Organization 84: 461-469.
21. Sharma U, Kishore J, Garg A, Anand T, Chakraborty M, et al (2013) Dyslipidemia and associated risk factors in a resettlement colony of Delhi. Journal of Clinical Lipidology 7: 653-660.
22. Gupta R, Prakash H, Kaul V (1997) Cholesterol lipoproteins, triglycerides, rural-urban differences and prevalence of dyslipidaemia among males in Rajasthan. J Assoc Phys Ind 45: 275-279. (Pubitemid 127519305) (Pubitemid 127519305)
23. Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, et al (2001) High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes Relat Metab Disord 25: 1722-1729. (Pubitemid 33052085) (Pubitemid 33052085)
24. Parikh RM, Joshi SR, Menon PS, Shah NS (2010) Prevalence and pattern of diabetic dyslipidemia in Indian type 2 diabetic patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 4: 10-12.
25. Joshi R, Taksande B, Kalantri SP, Jajoo UN, Gupta R (2013) Prevalence of cardiovascular risk factors among rural population of elderly in Wardha district. Journal of Cardiovascular Disease Research 4: 140-146.
26. Deepa R, Sandeep S, Mohan V (2006) Abdominal obesity, visceral fat and Type 2 diabetes - "Asian Indian Phenotype". In: Mohan V, Gundu HR Rao, editors. Type 2 diabetes in South Asians: Epidemiology, risk factors and prevention. New Delhi: Jaypee Brothers Medical Publishers p138-152.
27. Misra A, Luthra K, Vikram NK (2004) Dyslipidemia in Asian Indians: determinants and significance. J Assoc Physicians India 52: 137-142. (Pubitemid 44194615) (Pubitemid 44194615)
28. Mohan V, Deepa R, Rani SS, Premalatha G (2001) Prevalence of coronary artery disease and its relationship to lipid in a selected population in South India. J Am Coll Cardiol 38: 682-687. (Pubitemid 32835736) (Pubitemid 32835736)
29. Reaven GM (1988) Role of insulin resistance in human disease, Diabetes 37: 1595-1607.
30. Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global burden of Cardiovascular diseases: Part I: General considerations, the epidemiologic transition, risk factors and impact of urbanization. Circulation 104: 2746-2753. (Pubitemid 33108145) (Pubitemid 33108145)
31. Costa J, Borges M, David C, Vaz Carneiro A (2006) Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomized controlled trials. BMJ 332: 1115-1124.